✦ LIBER ✦

Use of fenoldopam to control renal dysfunction early after liver transplantation

✍ Scribed by Gianni Biancofiore; Giorgio Della Rocca; Lucia Bindi; Anna Romanelli; Massimo Esposito; Luca Meacci; Lucio Urbani; Franco Filipponi; Franco Mosca

Publisher: John Wiley and Sons
Year: 2004
Tongue: English
Weight: 102 KB
Volume: 10
Category: Article
ISSN: 1527-6465
DOI: 10.1002/lt.20145

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Acute renal failure after liver transpla

Acute renal failure after liver transplantation: The role of dopamine and fenoldopam

✍ Nelson Leung; Stephen C. Textor 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 48 KB

Treatment of renal dysfunction after ort

Treatment of renal dysfunction after orthotopic liver transplantation: Options and outcomes

✍ Thomas A. Gonwa 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 46 KB

Chronic nephrotoxicity is one of the most serious side-effects of calcineurin inhibitor treatment and a factor in mortality and morbidity after liver transplantation. In our transplant centre, among patients who underwent a liver transplantation between January 1989 and December 2000, 14 liver graft

Improvement of renal function after the

Improvement of renal function after the switch from a calcineurin inhibitor to everolimus in liver transplant recipients with chronic renal dysfunction

✍ Javier F. Castroagudín; Esther Molina; Rafael Romero; Esteban Otero; Santiago To 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 141 KB 👁 1 views

Chronic renal dysfunction is a frequent and severe complication in solid-organ transplant recipients. Calcineurin inhibitors (CNIs) are the main pathogenic factors of renal dysfunction. Switching from CNIs to nonnephrotoxic drugs, such as mammalian target of rapamycin inhibitors (everolimus and siro

Mycophenolate mofetil in combination wit

Mycophenolate mofetil in combination with reduction of calcineurin inhibitors for chronic renal dysfunction after liver transplantation

✍ Georges-Philippe Pageaux; Lionel Rostaing; Yvon Calmus; Christophe Duvoux; Clair 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB 👁 1 views

The purpose of the study was to introduce mycophenolate mofetil (MMF) in liver transplant recipients with renal dysfunction to decrease calcineurin inhibitor (CNI) dosages without increasing rejection risk. In this prospective, multicenter, randomized study, chronic CNI-related renal dysfunction was

Sonography: A useful tool to detect the

Sonography: A useful tool to detect the mechanical causes of renal transplant dysfunction

✍ Gottlieb, Ronald H.; Voci, Susan L.; Cholewinski, Scott P.; Hartley, Donna F.; R 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 456 KB 👁 1 views

## Purpose: The purpose of this study was to evaluate the utility of sonography in distinguishing between mechanical and nonmechanical causes for renal transplant dysfunction. ## Methods: We reviewed all ultrasound examination reports (n = 286) for 63 consecutive patients who received 64 renal tr

Cystatin C, an easy and reliable marker

Cystatin C, an easy and reliable marker for assessment of renal dysfunction in children with liver disease and after liver transplantation

✍ Marianne Samyn; Paul Cheeseman; Lynsey Bevis; Rachel Taylor; Beatrice Samaroo; M 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 103 KB 👁 1 views

Renal dysfunction of variable severity is being increasingly recognized as a major complication of calcineurin inhibitors (CI), in some patients even necessitating renal transplantation. Close and effective monitoring of the renal function is indicated. Current methods for this monitoring are calcul